Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Arbuckle

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
(R,R)-Disynephrine ether bis-(hydrogen sulfate)William Arbuckle, Alan R Kennedy, Catriona A Morrison
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
Disodium (2RS,3SR)-tartrateWilliam Arbuckle, Stuart Cartner, Alan R Kennedy, et al.
Bioorganic & Medicinal Chemistry Letters|June 25, 2011
Optimisation of pharmacokinetic properties to afford an orally bioavailable and selective V1A receptor antagonistWilliam Arbuckle, James Baker, David Barn, et al.
Bioorganic & Medicinal Chemistry Letters|April 5, 2011
The discovery of novel 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamides as vasopressin V1A receptor antagonistsSusan Napier, Grant Wishart, William Arbuckle, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
(R,R)-Disynephrine ether bis-(hydrogen sulfate)William Arbuckle, Alan R Kennedy, Catriona A Morrison
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
Disodium (2RS,3SR)-tartrateWilliam Arbuckle, Stuart Cartner, Alan R Kennedy, et al.
Bioorganic & Medicinal Chemistry Letters|June 25, 2011
Optimisation of pharmacokinetic properties to afford an orally bioavailable and selective V1A receptor antagonistWilliam Arbuckle, James Baker, David Barn, et al.
Bioorganic & Medicinal Chemistry Letters|April 5, 2011
The discovery of novel 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamides as vasopressin V1A receptor antagonistsSusan Napier, Grant Wishart, William Arbuckle, et al.
Pageof 1